Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H KELLER

Showing results (701-710 of 818) with videos related to

Pageof 82
Sort By:
The Journal of Biological Chemistry|March 21, 2013
NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complexYoung Mee Kim, Shovanlal Gayen, CongBao Kang, et al.
Journal of Medicinal Chemistry|July 4, 2017
Scaffold Hopping and Optimization of Maleimide Based Porcupine InhibitorsSoo Yei Ho, Jenefer Alam, Duraiswamy Athisayamani Jeyaraj, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2021
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune EtiologyAndrew J B Watts, Keith H Keller, Gabriel Lerner, et al.
Journal of Medicinal Chemistry|December 18, 2009
N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymeraseZheng Yin, Yen-Liang Chen, Ravinder Reddy Kondreddi, et al.
Circulation|April 22, 2009
A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertensionYing Yu, Steve H Keller, Carmelle V Remillard, et al.
The Journal of Biological Chemistry|December 15, 2010
Small molecule inhibitors that selectively block dengue virus methyltransferaseSiew Pheng Lim, Louis Sebastian Sonntag, Christian Noble, et al.
Journal of Medicinal Chemistry|August 15, 2012
Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidateNeil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Bioorganic & Medicinal Chemistry|October 2, 2021
Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitorsPearly Shuyi Ng, Klement Foo, Sandra Sim, et al.
Molecular Cancer Therapeutics|July 10, 2019
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer CellsJothi Anantharajan, Hengbo Zhou, Lingdi Zhang, et al.
Journal of Medicinal Chemistry|April 25, 2018
Fragment-Based Drug Discovery of Potent Protein Kinase C Iota InhibitorsJacek Kwiatkowski, Boping Liu, Doris Hui Ying Tee, et al.
Pageof 82

Showing results (701-710 of 818) with videos related to

Sort By:
Pageof 82
The Journal of Biological Chemistry|March 21, 2013
NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complexYoung Mee Kim, Shovanlal Gayen, CongBao Kang, et al.
Journal of Medicinal Chemistry|July 4, 2017
Scaffold Hopping and Optimization of Maleimide Based Porcupine InhibitorsSoo Yei Ho, Jenefer Alam, Duraiswamy Athisayamani Jeyaraj, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2021
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune EtiologyAndrew J B Watts, Keith H Keller, Gabriel Lerner, et al.
Journal of Medicinal Chemistry|December 18, 2009
N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymeraseZheng Yin, Yen-Liang Chen, Ravinder Reddy Kondreddi, et al.
Circulation|April 22, 2009
A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertensionYing Yu, Steve H Keller, Carmelle V Remillard, et al.
The Journal of Biological Chemistry|December 15, 2010
Small molecule inhibitors that selectively block dengue virus methyltransferaseSiew Pheng Lim, Louis Sebastian Sonntag, Christian Noble, et al.
Journal of Medicinal Chemistry|August 15, 2012
Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidateNeil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Bioorganic & Medicinal Chemistry|October 2, 2021
Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitorsPearly Shuyi Ng, Klement Foo, Sandra Sim, et al.
Molecular Cancer Therapeutics|July 10, 2019
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer CellsJothi Anantharajan, Hengbo Zhou, Lingdi Zhang, et al.
Journal of Medicinal Chemistry|April 25, 2018
Fragment-Based Drug Discovery of Potent Protein Kinase C Iota InhibitorsJacek Kwiatkowski, Boping Liu, Doris Hui Ying Tee, et al.
Pageof 82